Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abscess, intracerebral
addiction, heroin
advances in neurology
adverse drug reaction
alcohol, neurologic complications with
alcoholism
algorithm
angiography, cerebral
antibiotic prophylaxis
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
aphasia
arterial dissection
arterial dissection, aorta
arteriovenous malformation, pulmonary
bacterial endocarditis, neurologic manifestations of
blood pressure
brain purpura
cardiac tamponade
carotid artery disease, medical management
carotid artery occlusion, intracranial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, angiography, source images
CAT scan, chest
CAT scan, early changes in CVA
CAT scan, venography
cerebral edema
cerebral embolism
cerebral embolism, mechanical extraction
cerebral infarction, hemorrhagic
cerebral infarction, small, deep
cerebral ischemia
cerebral veins
cerebral venous infarction
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, complications with
cerebrovascular accident, delay in presentation
cerebrovascular accident, delay in treatment
cerebrovascular accident, mimics
cerebrovascular accident, recurrent
cerebrovascular accident, seizure with
cerebrovascular accident, severity
cerebrovascular accident, silent
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of presentation
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
chest x-ray, abnormal
children
chromosome 9
clot retrieval
clubbing of fingers
coagulopathy
comorbidities
complications
contraindications
controversies in neurology
cortical infarction, small
cortical vein thrombosis
coumarin
craniectomy, decompressive
critical care unit
cryoprecipitate
cyanosis
delay in diagnosis
diagnosis related group
diagnostic criteria
dizziness
doppler
doppler, transcranial
drug abuse
drug abuse, neurologic complications of
dural sinus thrombosis
echocardiogram
efficacy
embolism, paradoxical
emergencies, medical
emergencies, neurologic
endocarditis
endocarditis, infectious
endocarditis, prophylaxis
endovascular therapy
epidemiology of neurology
factor Xa inhibitor
familial
fibrinolytic agents
fibrinolytic agents, repeated use
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, deterioration following
fibrinolytic agents, exclusion criteria
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, intra-venous local infusion
fibrinolytic agents, utilization
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
gastrointestinal bleeding
gene
genetic testing
glucose level, serum
head injury
headache
headache, severe
hematoma, intracerebral
heparin
hereditary hemorrhagic telangiectasia(HHT)
hypertension
hypoxia
iatrogenic neurologic disorders
intracerebral hemorrhage
intracerebral hemorrhage, small
intracranial pressure, increased
intravenous drug abuse
lacunar infarction
lumbar puncture, complications of
mastoiditis
medical-legal aspects of neurology
menses
MERCI trial
microhemorrhage, intracerebral
middle cerebral artery, occlusion of
mimics
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, gradient-echo
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRI, venography
myocardial infarction
myocardial infarction, acute
neurologic disease, diagnoses of
neurologic examination, fluctuating
neurologic signs
neuroprotective agents
neuroradiology, interventional
NIH stroke scale
NIH stroke scale, fluctuating
non-vitamin K antagonist oral anticoagulants
old age, neurology of
opiate
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
otitis, neurologic complications with
partial thromboplastin time
partial thromboplastin time, prolonged
patient information and support
platelet count
platelet inhibiting drugs
platelet transfusion
posterior fossa, lesion of
postpartum
practice guidelines
pregnancy, neurologic complications in
prethrombotic state
prognosis
prothrombin time
protocol violations
recanalization, arterial
reperfusion
review article
risk factors
risk stratification
risk-benefit assessment
safety
screening
seizure
skin, lesions in neurologic disorders
solitaire device
sonothrombolysis
stent, intracranial
stroke disability scale
superior sagittal sinus thrombosis
SWIFT trial
symptomatic
telangiectases
thrombectomy
thrombocytopenia
thrombolysis, mechanical
tissue plasminogen activator, intravenous
Todd's paralysis
transient ischemic attack
treatment of neurologic disorder
Trevo retriever
ultrasonography
ultrasonography, head
vasculopathy
venogram, cerebral
visual field defect
visual impairment
visual loss
workup
Showing articles 650 to 700 of 5091 << Previous Next >>

Diffusion-perfusion MRI Characterization of Post-recanalization Hyperperfusion in Humans
Neurol 57:2015-2021, Kidwell,C.S.,et al, 2001

Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001

Thrombolytic Therapy in Acute Ischemic Stroke Patients With Cardiac Thrombus
Neurol 57:2122-2125, Derex,L.,et al, 2001

Treatment of Acute Basilar Artery Thrombosis With a Combination of Systemic Alteplase and Tirofiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Inhibitor: Report of Four Cases
Radiology 221:795-801, Junghans,U.,et al, 2001

Most Commonly Asked Questions About Intra-arterial Thrombolysis
The Neurologist 7:127-131, Wechsler,L.R., 2001

Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers
Stroke 32:1061-1068, Claiborne Johnston,S.,et al, 2001

Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Stroke 32:1074-1078, Koennecke,H.,et al, 2001

Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial
Stroke 32:661-668, Grotta,J.C.,et al, 2001

Benefits of Perfusion MR Imaging Relative to Diffusion MR Imaging in the Diagnosis and Treatment of Hyperacute Stroke
AJNR 22:915-921,806, Sunshine,J.L.,et al, 2001

Intraarterial Thrombolysis: Ready for Prime Time?
AJNR 22:55-58, Executive Committee of the ASITN, 2001

Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated with Symptomatic Intracerebral Hemorrhage
Stroke 32:12-16, Lopez-Yunez,A.M.,et al, 2001

Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001

Combined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke
AJNR 22:352-358, Keris,V.,et al, 2001

Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001

CT Angiography in the Rapid Triage of Patients with Hyperacute Stroke to Intraarterial Thrombolysis: Accuracy in the Detection of Large Vessel Thrombus
J Comput Assist Tomogr 25:520-528, Lev,M.H.,et al, 2001

Risk of Stroke Associated With Abciximab Among Patients Undergoing Percutaneous Coronary Intervention
JAMA 286:78-82, Akkerhuis,K.M.,et al, 2001

Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001

Thrombolysis of Extracranial and Intracranial Arteries After IV Abciximab
Neurol 56:1582-1584, Houdart,E.,et al, 2001

Rescue Treatment with Abciximab in Acute Ischemic Stroke
Neurol 56:1585-1587, Lee,K.Y.,et al, 2001

Cooling for Acute Ischemic Brain Damage (COOL AID)
Stroke 32:1847-1854, Krieger,D.W.,et al, 2001

Treatment with Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients with Ischemic Stroke Treated in Community Hospitals
Stroke 32:1832-1839,1840, Reed,S.D.,et al, 2001

Toxic Leukoencephalopathy
NEJM 345:425-432, Filley,C.M. &Kleinschmidt-DeMasters,B.K., 2001

Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke
Stroke 32:861-865, Katzan,I.L.,et al, 2001

New Imaging Strategies for Patient Selection for Thrombolytic and Neuroprotective Therapies
Neurol 57:S48-S52, Warach,S., 2001

Intra-Arterial Thrombolysis
Neurol 57:S58-S60, Saver,J.L., 2001

Parenchymal Hyperdensity on Computed tomography after Intra-Arterial Reperfusion Therapy for Acugte Middle Cerebral Artery Occlusion,Incidence and Clinical Significance
Stroke 32:2042-2048, Nakano,S.,et al, 2001

Early Carotid Endarterectomy for Critical Carotid Artery Stenosis After Thrombolysis Therapy in Acute Ischemic Stroke in the Middle Cerebral Artery
Stroke 32:2075-2080, McPherson,C.M.,et al, 2001

Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated with Intra-Arterial thrombolysis,Prediction of Final Infarct Volume and Clinical Outcome
Stroke 32:2021-2028, Lev,M.H.,et al, 2001

Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000

Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000

Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis
Stroke 31:1420-1425, Chow,K.,et al, 2000

Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI
Stroke 31:1318-1328, Schellinger,P.D.,et al, 2000

Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000

Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000

Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000

Identification of lacunar Infarcts Before Thrombolysis in the ECASS I Study
Neurol 54:684-688, Toni,D.,et al, 2000

rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000

Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000

Diagnosis and Treatment of Intravascular Lymphomatosis
ArchNeurol 57:374-377, Baumann,T.P.,et al, 2000

Diagnosis and Treatment of Acute Encephalitis
The Neurologist 6:145-159, Davis,L.E., 2000

Intravenous tPA in Acute Ischemic Stroke Related to Internal Carotid Artery Dissection
Neurol 54:2159-2161, Derex,L.,et al, 2000

Early Stroke Treatment Associated with Better Outcome
Neurol 55:1649-1655, Marler,J.R.,et al, 2000

Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000

Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000

Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000

Treatment of Intraventricular Hemorrhage with Urokinase
Stroke 31:841-847, Naff,N.J.,et al, 2000

Stereotactic Computed Tomographic-Guided Aspiration and Thrombolysis of Intracerebral Hematoma
Stroke 31:834-840, Montes,J.M.,et al, 2000

Thrombolytic Reversal of Acute Human Cerebral Ischemic Injury Shown by Diffusion/Perfusion Magnetic Resonance imaging
Ann Neurol 47:462-469, Kidwell,C.S.,et al, 2000

Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000



Showing articles 650 to 700 of 5091 << Previous Next >>